The papain-like protease from the severe acute respiratory syndrome coronavirus is a deubiquitinating enzyme

Journal of Virology

Volumn 79, Issue 24, 2005, Pages 15199-15208

  Lindner, Holger A ^a   Fotouhi Ardakani, Nasser ^a   Lytvyn, Viktoria ^a   Lachance, Paule ^a   Sulea, Traian ^a   Ménard, Robert ^a  

^a NATIONAL RESEARCH COUNCIL CANADA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALDEHYDE DERIVATIVE; AMINO ACID; COUMARIN DERIVATIVE; ENZYME INHIBITOR; HERPESVIRUS ASSOCIATED UBIQUITIN SPECIFIC PROTEASE; HYBRID PROTEIN; PAPAIN LIKE PROTEASE; POLYPROTEIN; POLYUBIQUITIN; PROTEINASE; SYNTHETIC PEPTIDE; UBIQUITIN; UBIQUITIN 7 AMINO 4 METHYLCOUMARIN; UNCLASSIFIED DRUG;

ARTICLE; BIOINFORMATICS; CARBOXY TERMINAL SEQUENCE; CHEMICAL BOND; CONTROLLED STUDY; DEUBIQUITINATION; ENZYME INHIBITION; ENZYME MECHANISM; ENZYME PURIFICATION; ENZYME SUBSTRATE; ESCHERICHIA COLI; HELA CELL; HOST CELL; HUMAN; HUMAN CELL; HYDROLYSIS; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROCESSING; SARS CORONAVIRUS; UBIQUITINATION; VIRUS CELL INTERACTION; VIRUS REPLICATION;

AMINO ACID SEQUENCE; CATALYTIC DOMAIN; HELA CELLS; HUMANS; MOLECULAR SEQUENCE DATA; PAPAIN; PEPTIDE HYDROLASES; SARS VIRUS; SEVERE ACUTE RESPIRATORY SYNDROME; SUBSTRATE SPECIFICITY; UBIQUITIN;

CORONAVIRUS; ESCHERICHIA COLI; HERPESVIRIDAE; SARS CORONAVIRUS;

EID: 29744463886     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.79.24.15199-15208.2005     Document Type: Article

References (46)

1. Amerik, A. Y., and M. Hochstrasser. 2004, Mechanism and function of deubiquitinating enzymes. Biochim. Biophys. Acta 1695:189-207.
2. Andres, G., A. Alejo, C. Simon-Mateo, and M. L. Salas. 2001. African swine fever virus protease. a new viral member of the SUMO-1-specific protease family. J. Biol. Chem. 276:780-787.
3. Baker, R. T. 1996. Protein expression using ubiquitin fusion and cleavage. Curr. Opin. Biotechnol. 7:541-546.
4. Balakirev, M. Y., M. Jaquinod, A. L. Haas, and J. Chroboczek. 2002. Deubiquitinating function of adenovirus proteinase. J. Virol. 76:6323-6331.
5. Bradford, M. M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248-254.
6. Butt, T. R., S. C. Edavettal, J. P. Hall, and M. R. Mattern. 2005. SUMO fusion technology for difficult-to-express proteins. Protein Expr. Purif. 42:1-9.
7. Cass, B., P. L. Pham, A. Kamen, and Y. Durocher. 2005. Purification of recombinant proteins from mammalian cell culture using a generic double-affinity chromatography scheme. Protein Expr. Purif. 40:77-85.
8. Chung, C. H., and S. H. Baek. 1999. Deubiquitinating enzymes: their diversity and emerging roles. Biochem. Biophys. Res. Commun. 266:633-640.
9. Cinatl, J., B. Morgenstern, G. Bauer, P. Chandra, H. Rabenau, and H. W. Doerr. 2003. Treatment of SARS with human interferons. Lancet 362:293-294.
10. Dang, L. C., F. D. Melandri, and R. L. Stein. 1998. Kinetic and mechanistic studies on the hydrolysis of ubiquitin C-terminal 7-amido-4-methylcoumarin by deubiquitinating enzymes. Biochemistry 37:1868-1879.
11. Dao, C. T., and D. E. Zhang. 2005. ISG15: a ubiquitin-like enigma. Front. Biosci. 10:2701-2722.
12. Dixon, M. 1953. The determination of enzyme inhibitor constants. Biochem. J. 1:170-171.
13. Durocher, Y., S. Perret, and A. Kamen. 2002. High-level and high-throughput recombinant protein production by transient transfection of suspension-growing human 293-EBNA1 cells. Nucleic Acids Res. 30:E9.
14. Glickman, M. H., and A. Ciechanover. 2002. The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction. Physiol. Rev. 82:373-428.
15. Haagmans, B. L., T. Kuiken, B. E. Martina, R. A. Fouchier, G. F. Rimmelzwaan, G. van Amerongen, D. van Riel, T. de Jong, S. Itamura, K. H. Chan, M. Tashiro, and A. D. Osterhaus. 2004. Pegylated interferon-alpha protects type 1 pneumocytes against SARS coronavirus infection in macaques. Nat. Med. 10:290-293.
16. Harcourt, B. H., D. Jukneliene, A. Kanjanahaluethai, J. Bechill, K. M. Severson, C. M. Smith, P. A. Rota, and S. C. Baker. 2004. Identification of severe acute respiratory syndrome coronavirus replicase products and characterization of papain-like protease activity. J. Virol. 78:13600-13612.
17. Hemelaar, J., A. Borodovsky, B. M. Kessler, D. Reverter, J. Cook, N. Kolli, T. Gan-Erdene, K. D. Wilkinson, G. Gill, C. D. Lima, H. L. Ploegh, and H. Ovaa. 2004. Specific and covalent targeting of conjugating and deconjugating enzymes of ubiquitin-like proteins. Mol. Cell. Biol. 24:84-95.
18. Herold, J., S. G. Siddell, and A. E. Gorbalenya. 1999. A human RNA viral cysteine proteinase that depends upon a unique Zn2+-binding finger connecting the two domains of a papain-like fold. J. Biol. Chem. 274:14918-14925.
19. Hershko, A., and I. A. Rose. 1987. Ubiquitin-aldehyde: a general inhibitor of ubiquitin-recycling processes. Proc. Natl. Acad. Sci. USA 84:1829-1833.
20. Hu, M., P. Li, M. Li, W. Li, T. Yao, J. W. Wu, W. Gu, R. E. Cohen, and Y. Shi. 2002. Crystal structure of a UBP-family deubiquitinating enzyme in isolation and in complex with ubiquitin aldehyde. Cell 111:1041-1054.
21. Hui, D. S., and G. W. Wong. 2004, Advancements in the battle against severe acute respiratory syndrome. Expert. Opin. Pharmacother. 5:1687-1693.
22. Johnston, S. C., S. M. Riddle, R. E. Cohen, and C. P. Hill. 1999. Structural basis for the specificity of ubiquitin C-terminal hydrolases. EMBO J. 18:3877-3887.
23. Kim, J. H., K. C. Park, S. S. Chung, O. Bang, and C. H. Chung. 2003. Deubiquitinating enzymes as cellular regulators. J. Biochem. (Tokyo) 134:9-18.
24. Knight, E. J., D. Fahey, B. Cordova, M. Hillman, R. Kutny, N. Reich, and D. Blomstrom. 1988. A 15-kDa interferon-induced protein is derived by COOH-terminal processing of a 17-kDa precursor. J. Biol. Chem. 263:4520-4522.
25. pro. J. Virol. 79:7239-7247.
26. Lau, Y. L., and J. M. Peiris. 2005. Pathogenesis of severe acute respiratory syndrome. Curr. Opin. Immunol. 17:404-410.
27. Lee, J. I., S. K. Woo, K. I. Kim, K. C. Park, S. H. Baek, Y. J. Yoo, and C. H. Chung. 1998. A method for assaying deubiquitinating enzymes. Biol. Proc. Online 1:92-99.
28. Malakhov, M. P., O. A. Malakhova, K. I. Kim, K. J. Ritchie, and D. E. Zhang. 2002. UBP43 (USP18) specifically removes ISG15 from conjugated proteins. J. Biol. Chem. 277:9976-9981.
29. Matsudaira, P. 1987. Sequence from picomole quantities of proteins electroblotted onto polyvinylidene difluoride membranes. J. Biol. Chem. 262:10035-10038.
30. Quesada, V., A. Diaz-Perales, A. Gutierrez-Fernandez, C. Garabaya, S. Cal, and C. Lopez-Otin, 2004. Cloning and enzymatic analysis of 22 novel human ubiquitin-specific proteases. Biochem. Biophys. Res. Commun. 314:54-62.
31. Ritchie, K. J., C. S. Hahn, K. I. Kim, M. Yan, D. Rosario, L. Li, J. C. de la Torre, and D. E. Zhang. 2004. Role of ISG15 protease UBP43 (USP18) in innate immunity to viral infection, Nat. Med. 10:1374-1378.
32. Sambrook, J., and D. W. Russell. 2001. Molecular cloning: a laboratory manual, 3rd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
33. Schlicke, M., and S. Brakmann. 2005. Expression and purification of histidine-tagged bacteriophage T7 DNA polymerase. Protein Expr. Purif. 39:247-253.
34. Skowronski, D. M., C. Astell, R. C. Brunham, D. E. Low, M. Petric, R. L. Roper, P. J. Talbot, T. Tam, and L. Babiuk. 2005. Severe acute respiratory syndrome (SARS): a year in review. Annu, Rev. Med. 56:357-381.
35. Snijder, E. J., P. J. Bredenbeek, J. C. Dobbe, V. Thiel, J. Ziebuhr, L. L. Poon, Y. Guan, M. Rozanov, W. J. Spaan, and A. E. Gorbalenya. 2003. Unique and conserved features of genome and proteome of SARS-coronavirus, an early split-off from the coronavirus group 2 lineage. J. Mol. Biol. 331:991-1004.
36. Soboleva, T. A., and R. T. Baker. 2004. Deubiquitinating enzymes: their functions and substrate specificity. Curr. Protein Pept. Sci. 5:191-200.
37. Sulea, T., H. A. Lindner, E. O. Purisima, and R. Menard. 2005. Deubiquitination, a new function of the severe acute respiratory syndrome coronavirus papain-like protease? J. Virol. 79:4550-4551.
38. Teng, H., J. D. Pinon, and S. R. Weiss. 1999. Expression of murine coronavirus recombinant papain-like proteinase: efficient cleavage is dependent on the lengths of both the substrate and the proteinase polypeptides. J. Virol. 73:2658-2666.
39. Thiel, V., K. A. Ivanov, A. Putics, T. Hertzig, B. Schelle, S. Bayer, B. Weissbrich, E. J. Snijder, H. Rabenau, H, W. Doerr, A. E. Gorbalenya, and J. Ziebuhr. 2003. Mechanisms and enzymes involved in SARS coronavirus genome expression. J. Gen. Virol. 84:2305-2315.
40. Weissman, A. M. 2001. Themes and variations on ubiquitylation. Nat. Rev. Mol. Cell Biol. 2:169-178.
41. Wilkinson, K. D. 1997. Regulation of ubiquitin-dependent processes by deubiquitinating enzymes. FASEB J. 11:1245-1256.
42. World Health Organization. 2004. Summary of probable SARS cases with onset of illness from 1 November 2002 to 31 July 2003. Communicable Disease Surveillance and Response (CSR). [Online.] http://www.who.int/csr /sars/country/table2004_04_21/en.
43. Yuan, W., and R. M. Krug. 2001. Influenza B virus NS1 protein inhibits conjugation of the interferon (IFN)-induced ubiquitin-like ISG15 protein. EMBO J. 20:362-371.
44. Ziebuhr, J., E. J. Snijder, and A. E. Gorbalenya. 2000. Virus-encoded proteinases and proteolytic processing in the Nidovirales. J. Gen. Virol. 81:853-879.
45. Ziebuhr, J., V. Thiel, and A. E. Gorbalenya. 2001. The autocatalytic release of a putative RNA virus transcription factor from its polyprotein precursor involves two paralogous papain-like proteases that cleave the same peptide bond. J. Biol. Chem. 276:33220-33232.
46. Ziebuhr, J. 2005. The coronavirus replicase. Curr. Top. Microbiol. Immunol. 287:57-94.